南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (9): 2159-2172.doi: 10.12122/j.issn.1673-4254.2026.09.15

• • 上一篇    

MIS18BP1经PI3K/AKT通路调控肾癌细胞上皮-间充质转化、增殖和迁移

赵保凤1,2(), 谭雪莹2, 梁雪雯2,3, 潘玉垚2,3, 原江水2(), 宋卫青2()   

  1. 1.青岛大学基础医学院病原生物学系,山东 青岛 266071
    2.青岛市市立医院检验科,山东 青岛 266011
    3.山东省第二医科大学医学检验学院,山东 潍坊 261053
  • 收稿日期:2026-01-20 出版日期:2026-09-20 发布日期:2026-09-30
  • 通讯作者: 原江水,宋卫青 E-mail:zbf12340316@163.com;yjs19790104@163.com;songweiqing68@163.com
  • 作者简介:赵保凤,在读硕士研究生,E-mail:zbf12340316@163.com
  • 基金资助:
    国家自然科学基金(31971191)

MIS18BP1 regulates epithelial-mesenchymal transition, proliferation, and migration of renal cancer cells via the PI3K/AKT pathway

Baofeng ZHAO1,2(), Xueying TAN2, Xuewen LIANG2,3, Yuyao PAN2,3, Jiangshui YUAN2(), Weiqing SONG2()   

  1. 1.Department of Pathogenic Biology, School of Basic Medical Sciences, Qingdao University, Qingdao 266071, China
    2.Department of Clinical Laboratory, Qingdao Municipal Hospital, Qingdao 266011, China
    3.College of Medical Laboratory Science, Shandong Second Medical University, Weifang 261053, China
  • Received:2026-01-20 Online:2026-09-20 Published:2026-09-30
  • Contact: Jiangshui YUAN, Weiqing SONG E-mail:zbf12340316@163.com;yjs19790104@163.com;songweiqing68@163.com
  • Supported by:
    National Natural Science Foundation of China(31971191)

摘要:

目的 探讨MIS18BP1通过PI3K/AKT信号通路调控肾癌细胞上皮-间充质转化(EMT)、增殖和迁移的作用及分子机制。 方法 基于TCGA和GEO数据库分析MIS18BP1在肾透明细胞癌(KIRC)中的表达特征,并通过免疫组化验证在肾癌及癌旁组织中的表达差异,进一步探讨其诊断价值及与临床病理参数、免疫浸润的相关性(P<0.05);采用加权基因共表达网络分析(WGCNA)筛选MIS18BP1相关基因模块并进行功能富集分析;通过慢病毒转染技术敲低肾癌细胞系786-O和ACHN中MIS18BP1的表达,采用CCK-8、克隆形成、Transwell与划痕愈合实验检测细胞增殖与迁移能力;Western blotting检测EMT标志蛋白(E-cadherin、N-cadherin、Vimentin)及PI3K/AKT通路关键蛋白(PI3K、p-AKT、AKT)的表达变化,进一步采用740Y-P(PI3K激活剂)处理进行回复实验。 结果 MIS18BP1在KIRC组织中高表达,与正常肾上皮细胞HK-2相比,MIS18BP1在786-O和ACHN中均升高,其表达水平与肿瘤TNM分期、病理分级呈正相关,且对KIRC具有良好的诊断效能(AUC=0.693~0.885);WGCNA与富集分析显示MIS18BP1相关基因富集于PI3K/AKT信号通路;细胞实验证实,敲低MIS18BP1可抑制肾癌细胞的增殖、迁移与克隆形成能力(P<0.05),同时下调N-cadherin、Vimentin表达,上调E-cadherin表达,并降低PI3K与AKT的磷酸化水平(P<0.05)。740Y-P处理可部分逆转敲低MIS18BP1所致的增殖和迁移抑制效应。 结论 MIS18BP1在肾癌中高表达且与不良临床特征相关,其可能通过激活PI3K/AKT信号通路促进EMT进程,从而增强肾癌细胞的增殖与迁移能力。

关键词: MIS18BP1, 肾透明细胞癌, PI3K/AKT信号通路, 上皮-间充质转化, 细胞增殖, 细胞迁移

Abstract:

Objective To explore the regulatory role of MIS18BP1 in epithelial-mesenchymal transition (EMT), proliferation, and migration of renal cancer cells and its molecular mechanism. Methods TCGA and GEO databases were used to analyze the expression patterns of MIS18BP1 in kidney renal clear cell carcinoma (KIRC), and its differential expression between tumor and adjacent tissues was validated by immunohistochemistry. The diagnostic value of MIS18BP1 and its correlation with clinicopathological parameters and immune infiltration were evaluated. Weighted gene co-expression network analysis (WGCNA) was performed to identify MIS18BP1-related gene modules for functional enrichment analysis. In renal cancer cell lines (786-O and ACHN), the effects of lentivirus-mediated MIS18BP1 knockdown on cell proliferation and migration were evaluated using CCK-8, colony formation, Transwell, and wound healing assays. Western blotting was performed to determine the expression levels of EMT-related proteins and PI3K/AKT pathway-related proteins, and rescue experiments were carried out using 740Y-P (a PI3K activator). Results MIS18BP1 was significantly overexpressed in KIRC tissues and in 786-O and ACHN cells compared with normal renal epithelial cells (HK-2). MIS18BP1 expression level was positively correlated with TNM stage and pathological grade, and showed good diagnostic performance for KIRC (AUC=0.693-0.885). WGCNA and enrichment analyses indicated that MIS18BP1-related genes were significantly enriched in the PI3K/AKT signaling pathway. In cultured renal cancer cells, MIS18BP1 knockdown significantly inhibited the proliferation, migration, and colony-forming ability of the cells, resulting also in decreased expression of N-cadherin and vimentin, increased expression of E-cadherin, and significantly lowered phosphorylation levels of PI3K and AKT. Treatment with 740Y-P partially reversed the inhibitory effects of MIS18BP1 knockdown on cell proliferation and migration. Conclusion MIS18BP1 is overexpressed in renal cancer and is associated with unfavorable clinical features. High expression of MIS18BP1 enhances proliferation and migration of renal cancer cells possibly by promoting EMT via activating the PI3K/AKT signaling pathway.

Key words: MIS18BP1, clear cell renal cell carcinoma, PI3K/AKT signaling pathway, epithelial-mesenchymal transition, cell proliferation, cell migration